| Aug 20 |
Ligand to Present at H.C. Wainwright 26th Annual Global Investment Conference
|
| Aug 16 |
Looking Into Ligand Pharmaceuticals's Recent Short Interest
|
| Aug 15 |
Ligand Pharmaceuticals (NASDAQ:LGND) Shareholders Should Be Cautious Despite Solid Earnings
|
| Aug 15 |
Private Capital's Strategic Moves Highlight Ligand Pharmaceuticals in Q2 2024
|
| Aug 12 |
Roth MKM says Small-Cap Value reaches key technical support, lists 14 "bullish" stocks
|
| Aug 10 |
Insider Buying: CEO Todd Davis Acquires Shares of Ligand Pharmaceuticals Inc (LGND)
|
| Aug 8 |
Ligand Pharmaceuticals Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
| Aug 7 |
Ligand Pharmaceuticals Incorporated (LGND) Q2 2024 Earnings Call Transcript
|
| Aug 6 |
Ligand Pharmaceuticals Incorporated 2024 Q2 - Results - Earnings Call Presentation
|
| Aug 6 |
Ligand Pharmaceuticals reports mixed Q2 results; reaffirms FY24 outlook
|
